Aggressive T-Cell Non-Hodgkin Lymphoma — Trials

Aggressive T-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

289 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 62
Recruiting: 32
Ph III recruiting: 3
Growth YoY: —
Industry share: 21%
Top sponsor: City of Hope Medical Center
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (47)

clinicaltrialsPublishedShowing 51–100 of 146 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01626664	KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)	completed	Phase 2	71	Kyowa Kirin, Inc.INDUSTRY	6	Apr 25, 2024	clinicaltrials
NCT06376721	Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma	recruiting	Phase 1 / Phase 2	43	Beijing Tongren HospitalOTHER	1	Apr 19, 2024	clinicaltrials